Originally published In Press as doi:10.1074/jbc.M111728200 on February 21, 2002
J. Biol. Chem., Vol. 277, Issue 19, 16498-16504, May 10, 2002
Peroxisomal Membrane Protein Import Does Not Require Pex17p*
Courtney C.
Harper
,
Sarah T.
South
,
J. Michael
McCaffery§, and
Stephen J.
Gould
¶
From the
Department of Biological Chemistry, The
Johns Hopkins University School of Medicine, Baltimore, Maryland
21205 and the § Integrated Imaging Center, Department of
Biology, The Johns Hopkins University, Baltimore, Maryland
21218
Received for publication, December 9, 2001, and in revised form, February 19, 2002
 |
ABSTRACT |
Of the ~20 proteins required for peroxisome
biogenesis, only four have been implicated in the process of
peroxisomal membrane protein (PMP) import: Pex3p, Pex16p, Pex17p, and
Pex19p. To improve our understanding of the role that Pex17p plays in
PMP import, we examined the behavior of PMPs in a Pichia
pastoris pex17 mutant. Relative to wild-type cells,
pex17 cells appeared to have a mild reduction in PMP
stability and slightly aberrant PMP behavior in subcellular
fractionation experiments. However, we also found that the behavior of
PMPs in the pex17 mutant was indistinguishable from PMP
behavior in a pex5 mutant, which has no defect in PMP import, and was far different from PMP behavior in a pex3
mutant, which has a bona fide defect in PMP import.
Furthermore, we found that a pex14 mutant, which has no
defect in PMP import, lacks detectable levels of Pex17p. Based on these
and other results, we propose that Pex17p acts primarily in the matrix
protein import pathway and does not play an important role in PMP import.
 |
INTRODUCTION |
Eukaryotic cells contain specialized organelles that enhance their
metabolic efficiency. Peroxisomes are a class of single-membrane bound
organelle that play important roles in lipid metabolism in virtually
all eukaryotes (1-3). Although eukaryotic cells can survive without
peroxisomes, defects in peroxisome biogenesis have significant
metabolic and developmental consequences. In humans, severe defects in
peroxisome biogenesis cause Zellweger syndrome, a lethal
neurological disorder (4, 5), and in yeast such defects eliminate
growth on fatty acids, an important carbon and energy source in natural
environments (3).
Approximately 20 PEX genes are required for peroxisome
biogenesis (6). Two major classes of peroxins have been identified. Most PEX genes are required for import of peroxisomal matrix
enzymes but are not required for peroxisome membrane biogenesis or
peroxisomal membrane protein
(PMP)1 import.
PEX5, which encodes the import receptor for most
newly synthesized peroxisomal matrix enzymes, is the exemplar of this class (7-13). The second major class of PEX genes is
required for the synthesis of peroxisomal membranes and/or the import
of PMPs; this group includes PEX3, PEX16,
PEX17, and PEX19 (4, 14). Pex3p is an integral
PMP that is necessary for the formation of peroxisomes. Yeast and human
pex3 mutants lack detectable peroxisomal structures, and
PMPs are either rapidly degraded or mislocalized to the mitochondrion
in these cells (8, 15). Similar phenotypes are observed in cells
lacking Pex19p (8, 16, 17), a putative import receptor/chaperone for
newly synthesized PMPs (17, 18) that interacts with PEX3
(19-21). Human PEX16, like PEX3 and
PEX19, is also required for peroxisome membrane biogenesis
and PMP import (22, 23), although it seems to function differently in
the yeast Yarrowia lipolyitca (24) and appears to be absent
from the yeast Saccharomyces cerevisiae (25). The fourth
peroxin implicated in PMP biogenesis is Pichia pastoris
Pex17p (26). This peroxin was identified in the yeast P. pastoris in a screen for mutants that are defective in the import
of a PMP-GFP fusion protein (26). Furthermore, the pex17
mutant was thought to import PMPs less efficiently than wild-type
cells. Based on these results, Snyder et al. (26) and
Subramani et al. (14) have proposed that Pex17p plays a
specific role in PMP import, with the matrix protein import defect of
pex17
cells resulting indirectly from this defect in PMP
biogenesis. These results are somewhat different from those reported
for S. cerevisiae PEX17, which appears to participate only
in matrix protein import (8, 27).
To improve our understanding of PMP import we began an investigation
into the role of PEX17 in this process. An analysis of pex17
cells revealed that they do have slightly reduced
levels of PMPs and that PMPs displayed an aberrant fractionation
behavior, at least as compared with wild-type (WT) cells. However, we
also observed these changes in pex5
mutants, which are
impaired in matrix protein import but unaffected in PMP import or
peroxisome membrane biogenesis. Furthermore, pex17
cells
show a phenotype that is very different from that of pex3
cells, which have a clear role in PMP biogenesis. Based on these and
other results, we conclude that P. pastoris Pex17p plays an
important role in peroxisomal matrix protein import but has no
detectable role in PMP import or any other aspect of PMP biogenesis.
 |
MATERIALS AND METHODS |
Yeast Strains--
The yeast strains used in this study are
listed in Table I. The pex3
mutant was generated by PCR-mediated gene disruption (28). A DNA
fragment containing the KanMX cassette (28), 90 base pairs
5' of the PEX3 open reading frame and 257 base pairs 3' of the PEX3 open reading frame was generated by PCR and
introduced into SGY55 by electroporation (29). Transformants were
selected on YPD plates containing 300 µg/ml G418. Replacement of the
PEX3 open reading frame with the KanMX cassette
was confirmed by PCR. Cells were grown in YPD (1% yeast extract, 2%
peptone, 2% dextrose), SYOLT (0.17% yeast nitrogen base without amino
acids or ammonium sulfate, 0.5% ammonium sulfate, 0.05%
L-histidine, 0.05% yeast extract, 0.18% oleic acid,
0.02% Tween 40), or SM (0.17% yeast nitrogen base without amino acids
or ammonium sulfate, 0.5% ammonium sulfate, 0.05% l-histidine, 0.5%
methanol) as described (29).
Antibodies, Protein Extracts, and Western
Blotting--
Antibodies to P. pastoris Pex10p and Pex12p
have been described previously (30, 31). Anti-Pex13p antibodies were a
generous gift from D. Crane (Griffith University, Brisbane,
Australia). We raised antibodies to a 19-amino acid peptide containing
the COOH-terminal 15 amino acids of P. pastoris Pex3p
(NH2-CKKKELNDLSASVYSNFDP-COOH). Anti-Pex17p antibodies were
raised to an MBP-Pex17p fusion protein expressed in and purified from
Escherichia coli (amino acids 1-267). Whole-cell lysates
were prepared as described (29) and detected by immunoblotting (29).
All differential centrifugation and density gradient centrifugation
experiments were performed as described previously (29).
Enzyme Assays--
Assays were performed on supernatant and
pellet fractions of postnuclear supernatants generated from oleic
acid-induced pex17
, pex5
, and WT strains
spun for 1 h at 250,000 × g.
Glyceraldehyde-3-phosphate dehydrogenase activity was determined at
25 °C by increasing A340 over 160 s.
Each fraction was diluted 30-fold into the reaction buffer (13 mM sodium pyrophosphate, pH 8.5, 26 mM sodium
arsenate, 25 µM NAD+, 3 mM
dithiothreitol), and the reaction was started with the addition of
DL-glyceraldehyde-3-phosphate to a concentration of 500 µM. Succinate dehydrogenase activity was determined by
incubating 25 µl of each lysate at 37 °C in the presence of 50 mM potassium phosphate, pH 6.8, 0.1%
p-iodonitrotetrazolene, and 50 mM
Na2 succinic acid for 10 min. The reactions were stopped by
the addition of trichloroacetic acid to 5%. Color was developed by the
addition of 1 ml of ethylene glycol monomethyl ether, and the
A440 was read.
Electron Microscopy--
Strains were induced in SM media as
described above. Yeast cells (at 24 °C) were pelleted, washed in
ddH20, 3% glutaraldehyde, 100 mM
cacodylate buffer, 5 mM CaCl2, and 5 mM MgCl2 for 1 h at room temperature, pH
7.4. Cells were then washed briefly in 100 mM cacodylate
buffer, pH 7.4, dispersed/embedded in 2% low temperature agarose
(~1:1), cooled, and subsequently cut into small blocks (~1
mm3). Blocks were then post-fixed in 4% KMnO4,
prepared in ddH2O for 1 h at room temperature, washed
thoroughly (4 times, 10 min total) in ddH2O, treated with
0.5% sodium meta-periodate for 15 min at room temperature, washed
twice in ddH2O, and placed into filtered 2% uranyl acetate
overnight at room temperature (in the dark). Blocks were then rapidly
dehydrated through a graded series of EtOH (4 °C), followed
by three washes in 100% EtOH (15 min each) and then two washes with
propylene oxide, and placed into a 50:50 mixture of propylene
oxide and Spurr resin. Samples were incubated overnight under
vacuum and were subsequently given two changes of Spurr resin over 6-8
h and left overnight in a third change under vacuum throughout the next
day. The samples were placed in beam capsules containing fresh Spurr
resin, which were placed in a polymerizing oven at 80 °C for
24-48 h. 60-nm sections were cut on a Leica UCT ultramicrotome,
collected onto 400-mesh nickel grids, post-stained with lead citrate
(2-5 min), and observed in a Philips EM 410 at 80 kV.
 |
RESULTS |
PMP Abundance and Distribution in P. pastoris pex17
Cells--
Previous studies have shown that defects in PMP import
result in rapid turnover and low steady state levels of most PMPs (8, 15-17, 23, 32). To determine whether this was also true for cells
lacking Pex17p, we examined the abundance of three integral PMPs in a
P. pastoris pex17
strain: Pex3p (33), Pex10p (30), and
Pex12p (31). To control for the specificity of any phenotypes we might
detect, we also examined the phenotypes of pex3
cells, which have a well established defect in PMP import (8, 15, 33), and
pex5
cells, which are defective in matrix protein import
but are not defective in PMP import (7-9). These strains were grown in
YPD to mid-log phase, washed, and incubated in oleate-containing medium for 18 h. Cells were then harvested and lysed, and
total cellular protein was collected by trichloroacetic acid
precipitation. Equal amounts of protein from each strain were separated
by SDS-PAGE and blotted with anti-PMP antibodies. As previously
reported for pex3
mutants of humans and S. cerevisiae, P. pastoris pex3
mutants had low steady
state levels of PMPs (Fig. 1). Steady
state levels of Pex3p, Pex10p, and Pex12p were also somewhat lower in
pex17
cells than in WT cells, although they were clearly
higher than in the pex3
strain. The levels of these three
PMPs in the pex5
cells were the same as in
pex17
cells. This was somewhat surprising given that all
prior studies of PMP biogenesis in pex5
mutants have
supported the hypothesis that Pex5p has no role in PMP import (7-13,
34).

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 1.
PMP abundance in WT,
pex3 ,
pex5 , and pex17
cells. Equal amounts of total cellular protein from WT,
pex3 , pex5 , and pex17 cells
were separated by SDS-PAGE, transferred to membranes, and probed with
antibodies for Pex3p, Pex10p, and Pex12p. The Pex12p antibody detected
two proteins, the larger of which is Pex12p (arrow).
|
|
To better understand the role of Pex17p in PMP import, we next used
subcellular fractionation experiments in an attempt to assess the
import of PMPs in pex17
cells, as well as in
pex3
, pex5
, and WT controls. Each strain
was grown in YPD, incubated in oleate-containing medium for 18 h,
and converted to spheroplasts. Cells were lysed in a Dounce homogenizer
and cleared of nuclei and cell debris by low speed centrifugation. The
resulting postnuclear supernatants (PNSs) were separated by
centrifugation at 25,000 × g for 30 min. Equal
proportions of each fraction were then separated by SDS-PAGE and
blotted with antibodies to Pex3p, Pex10p, and Pex12p (Fig.
2). The levels of these PMPs in extracts
prepared from pex3
cells were below the level of
detection. In cells lacking Pex17p, ~20-30% of the Pex10p and
Pex12p and ~50% of the Pex3p were detected in the 25kg
supernatant, which could be interpreted as evidence that
pex17
cells have a partial PMP import defect. However,
pex5
cells have a similar phenotype, raising questions about whether this assay is an accurate measure of PMP import.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 2.
PMP distribution in 25,000 × g supernatant and pellet fractions of WT,
pex3 ,
pex5 , and pex17
cells. PNSs were generated from oleic acid-induced WT,
pex3 , pex5 , and pex17 cells
and spun for 30 min at 25,000 × g. Equal portions of
the supernatant (S) and pellet (P) fractions were
separated by SDS-PAGE, transferred to membranes, and probed with
antibodies to Pex3p, Pex10p, and Pex12p.
|
|
Cells Lacking Pex17p Do Not Accumulate a Pool of Soluble,
Cytoplasmic PMPs--
Snyder et al. (26) previously
reported that the PMPs present in the 25,000 × g
supernatant fraction of pex17
mutant extracts were
largely resistant to sedimentation at higher speeds (100,000 × g). Based in part on this result, they concluded that
pex17
cells have a significant pool of soluble, cytosolic
PMPs (26). However, other studies have suggested that cell homogenates
contain significant levels of peroxisome-derived "microsomes" that
may pellet only at higher speeds (35-38). Postnuclear supernatants were again generated from oleic acid-induced pex17
,
pex5
, and WT strains and spun for 1 h at
250,000 × g. Enzymatic assays of glyceraldehyde-3-phosphate dehydrogenase and succinate dehydrogenase, which are cytosolic and mitochondrial enzymes, respectively,
demonstrate that these conditions are sufficient to pellet organelles
but not soluble proteins. Equal proportions of each fraction were then
separated by SDS-PAGE, transferred to membranes, and probed with
antibodies to Pex3p, Pex10p, and Pex12p (Fig.
3A). Under these conditions,
all three PMPs were found primarily in the pellet fraction of
pex17
cells. Similar results were observed for the pex5
mutant. Thus, it appears that PMPs present in the
25,000 × g supernatant of pex17
and
pex5
mutants do not represent pools of soluble, cytosolic
PMPs.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
PMPs of pex17
and pex5 cells sediment at
250,000 × g. A, PNSs prepared
from WT, pex5 , and pex17 strains were spun
at 250,000 × g for 1 h.
Glyceraldehyde-3-phosphate dehydrogenase (GAPD; a cytosolic
enzyme) and succinate dehydrogenase (SDH; a mitochondrial
enzyme) activities were determined as controls. B, levels of
PMPs extracted by high pH treatment. PNSs were extracted with 0.1 M Na2CO3, pH 11.5, and then spun at
250,000 × g for 1 h. Equal proportions of
supernatant (S) and pellet (P) fractions were
subjected to immunoblot with antibodies to Pex3p, Pex10p, and
Pex12p.
|
|
The sedimentation of Pex3p, Pex10p, and Pex12p from pex17
and pex5
lysates could reflect the insertion of these
proteins into peroxisomal membranes. However, their sedimentation
behavior could also reflect a more complicated situation. For example, a portion of each PMP may be properly inserted into peroxisome membranes, whereas other subsets of these PMPs may be only peripherally associated with membranes or may exist in large protein aggregates. To
determine the proportion of each PMP that was inserted into the
peroxisome membrane in each cell type, we incubated the PNSs from
pex17
, pex5
, and WT strains with 0.1 M Na2CO3, pH 11.5 (39), to extract
non-integral proteins from cellular membranes. Integral membrane
proteins were then collected in the pellet fraction by centrifugation
at 250,000 × g for 1 h. Equal proportions of each
fraction were then processed for immunoblot using antibodies to Pex3p,
Pex10p, and Pex12p (Fig. 3B). In both the
pex17
and pex5
mutants, ~50% of their
PMPs were released to the supernatant by carbonate extraction. The
amounts of PMPs released from WT peroxisome membranes were similar to
the amounts of PMPs released from pex17
and
pex5
mutants, although they corresponded to only 10% of
the total PMPs in WT cells as opposed to 50% of the PMPs in these two mutants.
The P. pastoris pex14 Mutant Lacks Both Pex14p and Pex17p--
As
part of our basic characterization of Pex17p, we examined its abundance
in an array of P. pastoris pex mutants. We generated antibodies to recombinant Pex17p. These antibodies recognize a protein
of ~25 kDa (the predicted molecular mass of Pex17p is 30,497 Da) in
P. pastoris cell extracts. The protein recognized by these
antibodies is absent from pex17
cells, colocalizes with peroxisomes in density gradient centrifugation experiments, and behaves
as an integral PMP, indicating that these antibodies are specific for
Pex17p (Fig. 4). These antibodies were
then used to assess the abundance of Pex17p in the pex1,
pex2, pex3, pex4, pex5,
pex6, pex8, pex10, pex12,
pex14, pex17, and pex22 mutants (Fig.
5). Whole cell lysates were generated by
alkaline lysis, and equal amounts of protein from each strain were
separated by SDS-PAGE, transferred to membranes, and probed with
anti-Pex17p antibodies. As a control, we determined the levels of
Pex13p in these same samples. As expected, Pex17p was absent from the
pex17
mutant. Levels were also reduced in the
pex3
mutant, consistent with the rapid degradation of all
known PMPs in these cells (8, 15, 32) (see Fig. 1). However, we
observed that Pex17p was also undetectable in the P. pastoris
pex14 mutant, and it is interesting to note that the
pex14 mutants of P. pastoris (40), S. cerevisiae (8, 41), and mammalian cells (42) have all been
reported to import PMPs normally. Pex17p abundance was slightly reduced in cells lacking Pex13p, another Pex14p-binding protein (40, 41, 43).
Equal loading and transfer of the pex14 sample can be
deduced from the fact that Pex13p levels were normal in this strain.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
Specificity of anti-Pex17p antibodies.
A, equal amounts of total cellular protein from WT and
pex17 cells were processed for immunoblot with
anti-pex17p antibodies. B, PNS was generated from oleic
acid-induced WT cells; this was then separated by centrifugation for 30 min at 25,000 × g. The resulting cytosolic supernatant
(S) and organelle pellet (P) were separated by
SDS-PAGE, and the distribution of Pex17p was examined. Pex17p is
localized to the peroxisomal pellet fraction. C, a WT PNS ± 0.1 M Na2CO3, pH 11.5, was separated at 250,000 × g for 1 h to pellet
all membranes. The resulting fractions were analyzed by Western blot to
determine the distribution of Pex17p. Pex17p is found predominantly in
the pellet fraction even after carbonate extraction, indicating that it
is an integral PMP. D, a WT PNS was fractionated by density
centrifugation in a 42.5-15% Nycodenz gradient. Fractions were
assayed for catalase ( ) and mitochondrial succinate dehydrogenase
(- - -) activity as well as for the presence of Pex17p by
immunostaining.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
Pex17p is undetectable in
pex14 cells. Whole-cell
protein extracts were generated from P. pastoris pex
mutants. Equal amounts of protein from each sample were separated by
SDS-PAGE and analyzed by Western blot. Pex17p is absent from
pex17 cells, is found at low levels in pex3
cells, and is absent from pex14 cells.
Antibodies against Pex13p were used as a loading control.
|
|
Cells Lacking Pex17p Contain Peroxisomes That Resemble Peroxisomes
of pex5
Cells--
The hypothesis that Pex17p may not play a role
in PMP import predicts that pex17
cells would display
peroxisome morphologies that are largely indistinguishable from those
of pex5
and pex14
cells. Electron
micrographic examination of these mutants supports this hypothesis
(Fig. 6). After induction of peroxisomes
by growth on methanol, wild-type cells accumulate many large,
electron-dense peroxisomes. In contrast, the pex3
mutant,
that has a bona fide PMP import defect, lacks detectable
peroxisomal structures. Peroxisomal structures of similar abundance and
morphology can be detected in the pex17
,
pex5
, and pex14
mutants. These are much
smaller and contain less electron-dense material than WT cells,
consistent with the matrix protein import defects in these
pex mutants.

View larger version (133K):
[in this window]
[in a new window]
|
Fig. 6.
Peroxisomes of pex17
cells are similar to those of pex5
and pex14 cells.
A, wild-type cells clearly demonstrate large/well defined
peroxisomes. B, pex3 cells show the absence of
peroxisomes. C and D, pex5 cells
have fewer/smaller peroxisomes. E-G, pex17
cells have fewer/smaller peroxisomes and peroxisomes of heterogeneous
morphology. H-K, pex14 cells also have
smaller/spherical peroxisomes. n, nucleus; m,
mitochondria; p, peroxisomes; V, vacuole.
Bars = 1 µm (A, B, C, E, and H)
and 0.1 µm (D, F, G, I, J, and K).
|
|
 |
DISCUSSION |
We investigated the hypothesis that Pex17p plays an important role
in PMP import (14, 26). The first consideration in trying to determine
whether a particular peroxin participates in matrix protein import or
PMP import is to determine whether the peroxin is essential for PMP
import. In the present study we established that P. pastoris
pex17
cells are able to import PMPs and assemble peroxisome
membranes, demonstrating conclusively that Pex17p is not required for
PMP import. This aspect of the pex17
phenotype contrasts
sharply with that of a bona fide PMP import mutant,
pex3
, in which PMPs are degraded rapidly because of their PMP import defect (8, 15, 32) and are virtually undetectable.
The second consideration in assessing the role of Pex17p in
PMP import is to determine whether its loss has a partial yet specific effect on PMP import. We did observe a slight
reduction in PMP abundance in the proportion of PMPs
that were inserted into the peroxisome membrane in P. pastoris pex17
cells. However, the question is whether
any mutant that is defective in peroxisomal matrix enzyme
import will also display these phenotypes or whether they reflect a
specific role for Pex17p in PMP import. We observed that cells lacking
Pex5p also displayed these phenotypes. Pex5p is the import receptor for
PTS1-containing peroxisomal matrix enzymes, and several previous
studies have concluded that Pex5p does not play any role in PMP import
(7-13, 34). Therefore, it is reasonable to conclude from these data
that Pex17p is unlikely to play a specific role in PMP import.
The phenotypes of the P. pastoris pex14 mutant (40)
contribute independent evidence that P. pastoris Pex17p does
not play a specific role in PMP import. Pex14p appears to function as
the docking factor for the PTS receptors in yeast (40, 41, 44) and
mammalian cells (42, 45). Numerous studies of pex14 mutants (8, 40-42, 44), including one of the P. pastoris pex14
mutant (40), have reached the conclusion that pex14
mutants have no detectable defect in PMP import. We found that
Pex17p levels are below the limit of detection in pex14
cells, demonstrating that the pex14 mutant is the equivalent
of a pex14,pex17 double mutant. Because the
P. pastoris pex14 mutant does not display any detectable defect in PMP import (40), it is highly unlikely that the P. pastoris pex17
mutant could have a PMP import defect.
The final argument against a role for Pex17p in PMP import comes from
studies of S. cerevisiae Pex17p (27). Peroxisomal matrix
protein import is severely affected in S. cerevisiae
pex17
mutants, but PMP import appears to be normal in these
cells. In a systematic side-by-side analysis of S. cerevisiae
pex mutants, Hettema et al. (8) established that PMP
abundance and distribution in pex17
cells was the same as
it was in the pex1, pex2, pex4, pex5, pex6, pex7, pex8,
pex10, pex11, pex12, pex13,
pex14, and pex15 mutants. Although there are some
peroxins that function differently in different species, these are
rare; and there is no precedent for such differences between P. pastoris and S. cerevisiae peroxins.
In addition to casting doubt on the hypothesis that Pex17p plays an
important role in PMP import (14, 26), our data revealed that the
fractionation behavior of PMPs in WT cells may be quite different from
that observed in pex mutants that have no specific defect in
PMP import. The pool of PMPs seen in pex5
and
pex17
mutants that did not sediment at 25,000 × g, which is sufficient to pellet most peroxisomes of WT
cells (29) (see Fig. 2), was also seen in other matrix protein import
mutants, including the pex4
, pex10
, and
pex14 mutants (data not shown). One explanation for these
results could be that the extremely small size of peroxisomes in
pex5
, pex17
, and many other pex
mutants precludes their quantitative sedimentation at speeds that are
known to sediment the large, enzyme-rich peroxisomes of WT cells. After
all, sedimentation behavior in these experiments is primarily a
function of size rather than density, with larger structures being
pelleted at lower centrifugation speeds and shorter centrifugation
times. As for the observation that a higher proportion of PMPs can be extracted by high pH buffer in these mutants (~50%) as compared with
WT cells (~10%), there is no difference between these mutants and WT
cells in regard to the absolute amounts of PMPs extracted by high pH
treatment (see Fig. 3B). The high pH-extractable PMPs we
detected in both WT cells and pex mutants may include PMPs that are bound to the membrane but not yet inserted in the bilayers or
merely large protein aggregates.
Although the above arguments indicate that there may, in fact, be
no actual defect in PMP import in the pex5
,
pex17
, and other pex mutants, it is also
possible that any mutant that is defective in matrix enzyme import will
display an ancillary, nonspecific impairment in PMP import. Peroxisomes
in these pex mutants are metabolically inactive, are far
smaller than normal peroxisomes, and appear to have far less surface
area than peroxisomes of WT cells. This situation may delay PMP import,
resulting in the accumulation of PMPs on the membrane surface and/or in
protein aggregates, which could also explain our fractionation data.
Regardless of the actual reason for our observation, it is clear
that an appropriate set of WT and mutant control strains is required to
distinguish between specific and nonspecific defects in PMP import.
Although the simplest interpretation of our data is that Pex17p acts
directly in matrix protein import and plays no specific role in PMP
import, it is not possible to exclude completely the possibility that
Pex17p plays a direct, minor role in PMP import. However, if the
available data are to be interpreted as evidence for such a role, then
one must also conclude that Pex5p and Pex14p participate directly in
PMP import, a conclusion that contradicts a large body of evidence
(7-13, 40-42, 44).
In addition to showing that Pex17p is unlikely to play an important
role in PMP import and most likely plays a direct role in peroxisomal
matrix protein import, we observed that Pex17p is undetectable in the
absence of Pex14p. Whether this dependence reflects a defect in Pex17p
synthesis or an enhancement in Pex17p degradation remains to be
determined, although a defect in Pex17p stability would appear
to be the more likely explanation. If true, this would lend additional
support to the hypothesis that Pex17p acts together with Pex14p, which
was originally proposed by Kunau and co-workers (27) based on the
interaction of Pex17p and Pex14p in vitro and in
vivo. The absence of Pex17p from pex14 mutants also
raises new questions about which phenotypes of pex14 mutants are caused by the loss of Pex14p and which result from the absence of Pex17p.
 |
FOOTNOTES |
*
This work was supported by grants from the National
Institutes of Health (DK45787 and DK59479 to S. J. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Biological Chemistry, The Johns Hopkins University School of
Medicine, Baltimore, MD 21205. Tel.: 410-955-3424 and -3085;
Fax: 410-955-0215; E-mail: sgould@jhmi.edu.
Published, JBC Papers in Press, February 21, 2002, DOI 10.1074/jbc.M111728200
 |
ABBREVIATIONS |
The abbreviations used are:
PMP, peroxisomal
membrane protein;
WT, wild type;
PNS, postnuclear supernatant.
 |
REFERENCES |
| 1.
|
Wanders, R. J.,
Vreken, P.,
Ferdinandusse, S.,
Jansen, G. A.,
Waterham, H. R.,
van Roermund, C. W.,
and Van Grunsven, E. G.
(2001)
Biochem. Soc. Trans.
29,
250-267[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Wanders, R. J.,
and Tager, J. M.
(1998)
Mol. Aspects Med.
19,
69-154[Medline]
[Order article via Infotrieve]
|
| 3.
|
Hettema, E. H.,
and Tabak, H. F.
(2000)
Biochim. Biophys. Acta
1486,
18-27[Medline]
[Order article via Infotrieve]
|
| 4.
|
Gould, S. J.,
and Valle, D.
(2000)
Trends Genet.
16,
340-344[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Gould, S. G.,
Valle, D.,
and Raymond, G. V.
(2001)
in
The Metabolic and Molecular Bases of Inherited Disease
(Scriver, C. R.
, Beaudet, A. L.
, Sly, W. S.
, and Valle, D., eds), 8th Ed., Vol. 2
, pp. 3181-3217, McGraw-Hill, New York
|
| 6.
|
Sacksteder, K. A.,
and Gould, S. J.
(2000)
Annu. Rev. Genet.
34,
623-652[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
McCollum, D.,
Monosov, E.,
and Subramani, S.
(1993)
J. Cell Biol.
121,
761-774[Abstract/Free Full Text]
|
| 8.
|
Hettema, E. H.,
Girzalsky, W.,
van Den Berg, M.,
Erdmann, R.,
and Distel, B.
(2000)
EMBO J.
19,
223-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Chang, C. C.,
South, S.,
Warren, D.,
Jones, J.,
Moser, A. B.,
Moser, H. W.,
and Gould, S. J.
(1999)
J. Cell Sci.
112,
1579-1590[Abstract]
|
| 10.
|
Dodt, G.,
Braverman, N.,
Wong, C.,
Moser, A.,
Moser, H. W.,
Watkins, P.,
Valle, D.,
and Gould, S. J.
(1995)
Nat. Genet.
9,
115-124[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
van der Leij, I.,
Franse, M. M.,
Elgersma, Y.,
Distel, B.,
and Tabak, H. F.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11782-11786[Abstract/Free Full Text]
|
| 12.
|
van der Klei, I. J.,
Hibrands, R. E.,
Swaving, G. J.,
Waterham, H. R.,
Vrieling, E. G.,
Titorenko, V. I.,
Cregg, J. M.,
Harder, W.,
and Veenhuis, M.
(1995)
J. Biol. Chem.
270,
17229-17236[Abstract/Free Full Text]
|
| 13.
|
Baes, M.,
Gressens, P.,
Baumgart, E.,
Carmeliet, P.,
Casteels, M.,
Fransen, M.,
Evrard, P.,
Fahimi, D.,
Declercq, P. E.,
Collen, D.,
van Veldhoven, P. P.,
and Mannaerts, G. P.
(1997)
Nat. Genet.
17,
49-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Subramani, S.,
Koller, A.,
and Snyder, W. B.
(2000)
Annu. Rev. Biochem.
69,
399-418[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
South, S. T.,
Sacksteder, K. A., Li, X.,
Liu, Y.,
and Gould, S. J.
(2000)
J. Cell Biol.
149,
1345-1360[Abstract/Free Full Text]
|
| 16.
|
Matsuzono, Y.,
Kinoshita, N.,
Tamura, S.,
Shimozawa, N.,
Hamasaki, M.,
Ghaedi, K.,
Wanders, R. J.,
Suzuki, Y.,
Kondo, N.,
and Fujiki, Y.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2116-2121[Abstract/Free Full Text]
|
| 17.
|
Sacksteder, K. A.,
Jones, J. M.,
South, S. T., Li, X.,
Liu, Y.,
and Gould, S. J.
(2000)
J. Cell Biol.
148,
931-944[Abstract/Free Full Text]
|
| 18.
|
Jones, J. M.,
Morrell, J. C.,
and Gould, S. J.
(2001)
J. Cell Biol.
153,
1141-1150[Abstract/Free Full Text]
|
| 19.
|
Gotte, K.,
Girzalsky, W.,
Linkert, M.,
Baumgart, E.,
Kammerer, S.,
Kunau, W.-H.,
and Erdmann, R.
(1998)
Mol. Cell. Biol.
18,
616-628[Abstract/Free Full Text]
|
| 20.
|
Snyder, W. B.,
Faber, K. N.,
Wenzel, T. J.,
Koller, A.,
Luers, G. H.,
Rangell, L.,
Keller, G. A.,
and Subramani, S.
(1999)
Mol. Biol. Cell
10,
1745-1761[Abstract/Free Full Text]
|
| 21.
|
Fransen, M.,
Wylin, T.,
Brees, C.,
Mannaerts, G. P.,
and Van Veldhoven, P. P.
(2001)
Mol. Cell. Biol.
21,
4413-4424[Abstract/Free Full Text]
|
| 22.
|
Honsho, M.,
Tamura, S.,
Shimozawa, N.,
Suzuki, Y.,
Kondo, N.,
and Fujiki, Y.
(1998)
Am. J. Hum. Genet.
63,
1622-1630[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
South, S. T.,
and Gould, S. J.
(1999)
J. Cell Biol.
144,
255-266[Abstract/Free Full Text]
|
| 24.
|
Eitzen, G. A.,
Szilard, R. K.,
and Rachubinski, R. A.
(1997)
J. Cell Biol.
137,
1265-1278[Abstract/Free Full Text]
|
| 25.
|
Tabak, H. F.,
Braakman, I.,
and Distel, B.
(1999)
Trends Cell Biol.
9,
447-453[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Snyder, W. B.,
Koller, A.,
Choy, A. J.,
Johnson, M. A.,
Cregg, J. M.,
Rangell, L.,
Keller, G. A.,
and Subramani, S.
(1999)
Mol. Biol. Cell
10,
4005-4019[Abstract/Free Full Text]
|
| 27.
|
Huhse, B.,
Rehling, P.,
Albertini, M.,
Blank, L.,
Meller, K.,
and Kunau, W. H.
(1998)
J. Cell Biol.
140,
49-60[Abstract/Free Full Text]
|
| 28.
|
Baker-Brachmann, C.,
Davies, A.,
Cost, G. J.,
Caputo, E., Li, J.,
Hieter, P.,
and Boeke, J. D.
(1998)
Yeast
14,
115-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Crane, D. I.,
Kalish, J. E.,
and Gould, S. J.
(1994)
J. Biol. Chem.
269,
21835-21844[Abstract/Free Full Text]
|
| 30.
|
Kalish, J. E.,
Theda, C.,
Morrell, J. C.,
Berg, J. M.,
and Gould, S. J.
(1995)
Mol. Cell. Biol.
15,
6406-6419[Abstract]
|
| 31.
|
Kalish, J. E.,
Keller, G. A.,
Morrell, J. C.,
Mihalik, S. J.,
Smith, B.,
Cregg, J. M.,
and Gould, S. J.
(1996)
EMBO J.
15,
3275-3285[Medline]
[Order article via Infotrieve]
|
| 32.
|
Kinoshita, N.,
Ghaedi, K.,
Shimozawa, N.,
Wanders, R. J. A.,
Matsuzono, Y.,
Imanaka, T.,
Okumoto, K.,
Suzuki, Y.,
Kondo, N.,
and Fujiki, Y.
(1998)
J. Biol. Chem.
273,
24122-24130[Abstract/Free Full Text]
|
| 33.
|
Wiemer, E. A. C.,
Luers, G. H.,
Faber, K. N.,
Wenzel, T.,
Veenhuis, M.,
and Subramani, S.
(1996)
J. Biol. Chem.
271,
18973-18980[Abstract/Free Full Text]
|
| 34.
|
Gatto, G. J., Jr.,
Geisbrecht, B. V.,
Gould, S. J.,
and Berg, J. M.
(2000)
Nat. Struct. Biol.
7,
1091-1095[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Heinemann, P.,
and Just, W. W.
(1992)
FEBS Lett.
300,
179-182[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
van Roermund, C. W. T.,
van den Berg, M.,
and Wanders, R. J. A.
(1995)
Biochim. Biophys. Acta
1245,
348-358[Medline]
[Order article via Infotrieve]
|
| 37.
|
Titorenko, V. I.,
Chan, H.,
and Rachubinski, R. A.
(2000)
J. Cell Biol.
148,
29-44[Abstract/Free Full Text]
|
| 38.
|
Titorenko, V. I.,
and Rachubinski, R. A.
(2000)
J. Cell Biol.
150,
881-886[Abstract/Free Full Text]
|
| 39.
|
Fujiki, Y.,
Hubbard, A. L.,
Fowler, S.,
and Lazarow, P. B.
(1982)
J. Cell Biol.
93,
97-102[Abstract/Free Full Text]
|
| 40.
|
Johnson, M. A.,
Snyder, W. B.,
Cereghino, J. L.,
Veenhuis, M.,
Subramani, S.,
and Cregg, J. M.
(2001)
Yeast
18,
621-641[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Albertini, M.,
Rehling, P.,
Erdmann, R.,
Girzalsky, W.,
Kiel, J. A. K. W.,
Veenhuis, M.,
and Kunau, W.-H.
(1997)
Cell
89,
83-92[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Shimizu, N.,
Itoh, R.,
Hirono, Y.,
Otera, H.,
Ghaedi, K.,
Tateishi, K.,
Tamura, S.,
Okumoto, K.,
Harano, T.,
Mukai, S.,
and Fujiki, Y.
(1999)
J. Biol. Chem.
274,
12593-12604[Abstract/Free Full Text]
|
| 43.
|
Girzalsky, W.,
Rehling, P.,
Stein, K.,
Kipper, J.,
Blank, L.,
Kunau, W. H.,
and Erdmann, R.
(1999)
J. Cell Biol.
144,
1151-1162[Abstract/Free Full Text]
|
| 44.
|
Komori, M.,
Rasmussen, S. W.,
Kiel, J. A.,
Baerends, R. J.,
Cregg, J. M.,
van der Klei, I. J.,
and Veenhuis, M.
(1997)
EMBO J.
16,
44-53[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Schliebs, W.,
Saidowsky, J.,
Agianian, B.,
Dodt, G.,
Herberg, F. W.,
and Kunau, W. H.
(1999)
J. Biol. Chem.
274,
5666-5673[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Girzalsky, L. S. Hoffmann, A. Schemenewitz, A. Nolte, W.-H. Kunau, and R. Erdmann
Pex19p-dependent Targeting of Pex17p, a Peripheral Component of the Peroxisomal Protein Import Machinery
J. Biol. Chem.,
July 14, 2006;
281(28):
19417 - 19425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Lin-Cereghino, L. Godfrey, B. J. de la Cruz, S. Johnson, S. Khuongsathiene, I. Tolstorukov, M. Yan, J. Lin-Cereghino, M. Veenhuis, S. Subramani, et al.
Mxr1p, a Key Regulator of the Methanol Utilization Pathway and Peroxisomal Genes in Pichia pastoris
Mol. Cell. Biol.,
February 1, 2006;
26(3):
883 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Leon, L. Zhang, W. H. McDonald, J. Yates III, J. M. Cregg, and S. Subramani
Dynamics of the peroxisomal import cycle of PpPex20p: ubiquitin-dependent localization and regulation
J. Cell Biol.,
January 3, 2006;
172(1):
67 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|